Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05839873 · ClinicalTrials.gov registry record
Abbott Ventricular Tachycardia PAS
A clinical trial of Ventricular Tachycardia, sponsored by Abbott Medical Devices.
- Active
- Registry status
- 62
- Enrollment target
- 11
- Study locations
NCT05839873: Active study of Ventricular Tachycardia, sponsored by Abbott Medical Devices.
NCT05839873 is a study of Ventricular Tachycardia that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 62 participants, below the 286-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (78% lower). The trial reports 11 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05839873, a study of Ventricular Tachycardia, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- 62 participants
- Enrollment target
- 11
- Study locations
Study Summary
This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospective, single arm, open-label, multi-center, observational study.
Conditions Studied
Interventions
- DEVICE FlexAbility SE Ablation Catheter
Study Locations (11)
Florida
- NCH Healthcare System - Naples
Indiana
- St. Vincent Hospital - Indianapolis
Kansas
- Kansas City Cardiac Arrhythmia Research Foundation - Overland Park
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- VA Medical Center Minneapolis - Minneapolis
North Carolina
- Carolinas Medical Center - Charlotte
Oklahoma
- Integris Baptist Medical Center - Oklahoma City
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2023-07-24 |
| Est. Completion | 2026-11 |
What the registry record for NCT05839873 still lists
NCT05839873 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 286-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which FlexAbility SE Ablation Catheter is the first listed.
NCT05839873 lists 11 locations in 11 states (Florida, Indiana, Kansas).
Frequently Asked Questions
What is clinical trial NCT05839873 about?
NCT05839873 is a clinical study titled "Abbott Ventricular Tachycardia PAS". This post-approval study (PAS) is designed to provide continued clinical evidence to confirm the long-term safety and effectiveness of the FlexAbilityTM Ablation Catheter, Sensor EnabledTM (FlexAbility SE) for the treatment of ventricular tachycardia in a post-market environment. This is a prospecti...
What is the current status of trial NCT05839873?
This trial is currently active not recruiting. The enrollment target is 62 participants. The study started on 2023-07-24. Estimated completion is 2026-11.
What conditions does trial NCT05839873 study?
This clinical trial studies the following conditions: Ventricular Tachycardia.
What interventions are being tested in trial NCT05839873?
The interventions under investigation include: FlexAbility SE Ablation Catheter (DEVICE).
Who is sponsoring clinical trial NCT05839873?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05839873 being conducted?
This trial has 11 study locations across Florida, Indiana, Kansas, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05839873's enrollment target sits among peer trials
62 19th of 28 higher than 10 of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation
RECRUITING
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI